These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Drugs for MRSA with reduced susceptibility to vancomycin. Med Lett Drugs Ther; 2009 May; 51(1311):36; quiz 37. PubMed ID: 19417720 [No Abstract] [Full Text] [Related]
8. [Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods]. Gómez-Garcés JL; López-Fabal F; Burillo A; Gil Y Rev Esp Quimioter; 2010 Jun; 23(2):87-92. PubMed ID: 20559607 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus. Hannan A; Absar M; Usman M; Naeem T; Saleem S; Arshad M J Ayub Med Coll Abbottabad; 2009; 21(1):106-9. PubMed ID: 20364755 [TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. Vidaillac C; Leonard SN; Rybak MJ Int J Antimicrob Agents; 2010 Jun; 35(6):527-30. PubMed ID: 20346632 [TBL] [Abstract][Full Text] [Related]
13. A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy. Cojutti P; Scarparo C; Sartor A; Coato P; Rigoli R; Pea F Diagn Microbiol Infect Dis; 2015 Jan; 81(1):53-6. PubMed ID: 25301716 [TBL] [Abstract][Full Text] [Related]
14. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains]. Efe S; Sinirtaş M; Ozakin C Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917 [TBL] [Abstract][Full Text] [Related]
15. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M; Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529 [TBL] [Abstract][Full Text] [Related]
16. Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Marconescu P; Graviss EA; Musher DM Scand J Infect Dis; 2012 Aug; 44(8):620-2. PubMed ID: 22668202 [TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA). Kaleem F; Usman J; Khalid A; Hassan A; Omair M J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. Samra Z; Ofer O; Shmuely H Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates. Mendes RE; Moet GJ; Janechek MJ; Jones RN Antimicrob Agents Chemother; 2010 Jun; 54(6):2704-6. PubMed ID: 20385851 [TBL] [Abstract][Full Text] [Related]
20. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Raad I; Hanna H; Jiang Y; Dvorak T; Reitzel R; Chaiban G; Sherertz R; Hachem R Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]